Rob Valuck, Ph.D.

Rob Valuck, Ph.D.

Co-founder and CEO of OpiSafe and Director of the Colorado Consortium for Prescription Drug Abuse Prevention

Rob is the CEO/co-founder of OpiSafe and a leading expert in prescription drug adherence and patient-focused outcomes with more than 25 years in the field of pharmaceutical sciences. He is passionate about improving the connection between people and their providers so they may fully benefit from their medications.

Rob is the CEO/co-founder of OpiSafe and a leading expert in prescription drug adherence and patient-focused outcomes with more than 25 years in the field of pharmaceutical sciences. He is passionate about improving the connection between people and their providers so they may fully benefit from their medications. He is a Professor in the Departments of Clinical Pharmacy, Epidemiology and Family Medicine at the University of Colorado Schools of Pharmacy, Public Health and Medicine at the Anschutz Medical Campus in Aurora, Colo. He is also the Director of the Center for Pharmaceutical Outcomes Research at the School of Pharmacy. His major areas of research include post-marketing studies of the beneficial and adverse effects of pharmaceuticals, with an emphasis on rare, serious adverse effects of psychotropic drugs. He has authored or co-authored dozens of medical journal articles, book chapters and abstracts. Rob is also Coordinating Center Director of the Colorado Consortium for Prescription Drug Abuse Prevention, created by Governor John Hickenlooper to address the prescription drug abuse problem with a collaborative, statewide approach. A Colorado native, he earned his B.S. in Pharmacy from the University of Colorado and holds master’s and Ph.D. degrees in Pharmacy from the University of Illinois at Chicago. When he’s not creating solutions to improve medication use and outcomes, Rob enjoys the Colorado outdoors with his sons and fly fishing, hiking and traveling.

Datica Leadership